Takara Bio (TSE:4974) Other Long-Term Liabilities : 円412 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Takara Bio Other Long-Term Liabilities?

Takara Bio's other long-term liabilities for the quarter that ended in Mar. 2024 was 円412 Mil.

Takara Bio's quarterly other long-term liabilities declined from Sep. 2023 (円1,179 Mil) to Dec. 2023 (円1,176 Mil) and declined from Dec. 2023 (円1,176 Mil) to Mar. 2024 (円412 Mil).

Takara Bio's annual other long-term liabilities declined from Mar. 2022 (円572 Mil) to Mar. 2023 (円562 Mil) and declined from Mar. 2023 (円562 Mil) to Mar. 2024 (円412 Mil).

Takara Bio Other Long-Term Liabilities Historical Data

The historical data trend for Takara Bio's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takara Bio Other Long-Term Liabilities Chart

Takara Bio Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Long-Term Liabilities

Get a 7-Day Free Trial

Takara Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Takara Bio Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Takara Bio Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Takara Bio's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Takara Bio (TSE:4974) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Takara Bio Inc (TSE:4974) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

TF2:Germany

Address

Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058

Website

http://www.takara-bio.co.jp

Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.

Takara Bio (TSE:4974) Headlines

No Headlines